相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Decrease post-transplant relapse using donor-derived expanded NK-cells
Stefan O. Ciurea et al.
LEUKEMIA (2022)
Natural killer cells in antitumour adoptive cell immunotherapy
Tamara J. Laskowski et al.
NATURE REVIEWS CANCER (2022)
NK cell-based cancer immunotherapy: from basic biology to clinical development
Sizhe Liu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)
Diagnosis, grading and management of toxicities from immunotherapies in children, adolescents and young adults with cancer
Dristhi Ragoonanan et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2021)
Optimizing the Procedure to Manufacture Clinical-Grade NK Cells for Adoptive Immunotherapy
Adrian Fernandez et al.
CANCERS (2021)
Adoptive immunotherapy with double-bright (CD56bright/CD16bright) expanded natural killer cells in patients with relapsed or refractory acute myeloid leukaemia: a proof-of-concept study
Lucia Silla et al.
BRITISH JOURNAL OF HAEMATOLOGY (2021)
Inhibitory Receptors and Immune Checkpoints Regulating Natural Killer Cell Responses to Cancer
Irina Buckle et al.
CANCERS (2021)
NK cells for cancer immunotherapy
Noriko Shimasaki et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors
Enli Liu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Evaluation of serum -free media formulations in feeder cell stimulated expansion of natural killer cells
Jena E. Moseman et al.
CYTOTHERAPY (2020)
Superior Expansion and Cytotoxicity of Human Primary NK and CAR-NK Cells from Various Sources via Enriched Metabolic Pathways
Yan Yang et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2020)
Cellular therapy: Adoptive immunotherapy with expanded natural killer cells
Dean A. Lee
IMMUNOLOGICAL REVIEWS (2019)
Natural killer cells: a review of biology, therapeutic potential and challenges in treatment of solid tumors
Khalil Choucair et al.
FUTURE ONCOLOGY (2019)
Membrane bound IL-21 based NK cell feeder cells drive robust expansion and metabolic activation of NK cells
Evelyn O. Ojo et al.
SCIENTIFIC REPORTS (2019)
Efficient and Robust NK-Cell Transduction With Baboon Envelope Pseudotyped Lentivector
Aurelien B. L. Colamartino et al.
FRONTIERS IN IMMUNOLOGY (2019)
Haploidentical IL-15/41BBL activated and expanded natural killer cell infusion therapy after salvage chemotherapy in children with relapsed and refractory leukemia
M. Vela et al.
CANCER LETTERS (2018)
An Uncoupling of Canonical Phenotypic Markers and Functional Potency of Ex Vivo-Expanded Natural Killer Cells
Nicole A. P. Lieberman et al.
FRONTIERS IN IMMUNOLOGY (2018)
Analysis of NK cell clones obtained using interleukin-2 and gene-modified K562 cells revealed the ability of senescent NK cells to lose CD57 expression and start expressing NKG2A
Maria A. Streltsova et al.
PLOS ONE (2018)
Natural Killer Cell-Based Cancer Immunotherapy: A Review on 10 Years Completed Clinical Trials
Wade Chun-Wai Suen et al.
CANCER INVESTIGATION (2018)
The More, The Better: Do the Right Thing For natural Killer immunotherapy in Acute Myeloid Leukemia
Sarah Parisi et al.
FRONTIERS IN IMMUNOLOGY (2017)
Ex vivo expanded natural killer cells from breast cancer patients and healthy donors are highly cytotoxic against breast cancer cell lines and patient-derived tumours
Mira M. Shenouda et al.
BREAST CANCER RESEARCH (2017)
Phase I study of cord blood-derived natural killer cells combined with autologous stem cell transplantation in multiple myeloma
Nina Shah et al.
BRITISH JOURNAL OF HAEMATOLOGY (2017)
Larger Size of Donor Alloreactive NK Cell Repertoire Correlates with Better Response to NK Cell Immunotherapy in Elderly Acute Myeloid Leukemia Patients
Antonio Curti et al.
CLINICAL CANCER RESEARCH (2016)
Donor-Derived Natural Killer Cells Infused after Human Leukocyte Antigen-Haploidentical Hematopoietic Cell Transplantation: A Dose-Escalation Study
Inpyo Choi et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
Growth and Activation of Natural Killer Cells Ex Vivo from Children with Neuroblastoma for Adoptive Cell Therapy
Yin Liu et al.
CLINICAL CANCER RESEARCH (2013)
Membrane-Bound IL-21 Promotes Sustained Ex Vivo Proliferation of Human Natural Killer Cells
Cecele J. Denman et al.
PLOS ONE (2012)
CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset
Sandra Lopez-Verges et al.
BLOOD (2010)
Allogeneic natural killer cells for refractory lymphoma
Veronika Bachanova et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Induction of CD16+ CD56bright NK cells with antitumour cytotoxicity not only from CD16- CD56bright NK cells but also from CD16- CD56dim NK cells
E. Takahashi et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2007)
Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer
JS Miller et al.
BLOOD (2005)